Albany Molecular Research (AMRI) Posts Q3 adj.-Loss of $0.12, Misses Views; Guides Q410, FY10
Tweet Send to a Friend
Albany Molecular Research, Inc. (Nasdaq: AMRI) reports Q3 adjusted loss of $0.12, versus the consensus of ($0.08.) Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
